Shares of HemaCare Co. (OTCMKTS:HEMA – Get Free Report) traded up 0.6% on Thursday . The stock traded as high as $25.31 and last traded at $25.31. 5,400 shares were traded during mid-day trading, a decline of 86% from the average session volume of 39,950 shares. The stock had previously closed at $25.16.
HemaCare Price Performance
The company has a fifty day simple moving average of $25.31 and a two-hundred day simple moving average of $25.31.
About HemaCare
HemaCare Corporation provides human-derived primary blood cells and tissues for biomedical research, and supporting cell therapy clinical trials and commercialization with apheresis collections in the United States. The company specializes in the customized collection, isolation, and testing of primary human blood cells and other biological products for research protocols and cellular therapy.
Recommended Stories
- Five stocks we like better than HemaCare
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Everything About Amazon Stock Signals a Buy—Time to Load Up?
- Stock Average Calculator
- 5 Reasons Five Below’s Stock Price Is Heading Higher This Year
- About the Markup Calculator
- Broadcom: Why the Chip Stock Remains a Top Long-Term AI Play
Receive News & Ratings for HemaCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HemaCare and related companies with MarketBeat.com's FREE daily email newsletter.
